Mechanisms of residual immune activation in HIV-1-infected human lymphoid tissue ex vivo

被引：0
|
作者：
Margolis, L. [1 ]
Mercurio, V. [1 ]
Fitzgerald, W. [1 ]
Vanpouille, C. [1 ]
Molodsov, I. [2 ]
机构：
[1] NICHHD, NIH, Bethesda, MD 20892 USA
[2] NF Gamaleya Fed Natl Res Ctr Epidemiol & Microbio, Moscow, Russia
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
OAA0102
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [41] Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
    Introini, Andrea
    Vanpouille, Christophe
    Fitzgerald, Wendy
    Broliden, Kristina
    Margolis, Leonid
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (140):
  • [42] Interactions between human immunodeficiency virus type 1 and vaccinia virus in human lymphoid tissue ex vivo
    Vanpouille, Christophe
    Bioncotto, Angelique
    Lisco, Andrea
    Brichacek, Beda
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (22) : 12458 - 12464
  • [43] Monocyte activation by circulating fibronectin fragments in HIV-1-infected patients
    Trial, J
    Rubio, JA
    Birdsall, HH
    Rodriguez-Barradas, M
    Rossen, RD
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (03): : 2190 - 2198
  • [44] Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy
    Koblavi-Dème, S
    Maran, M
    Kabran, N
    Borget, MY
    Kalou, M
    Kestens, L
    Maurice, C
    Sassan-Morokro, M
    Ekpini, ER
    Roels, TH
    Chorba, T
    Nkengasong, JN
    [J]. AIDS, 2003, 17 : S17 - S22
  • [45] MicroRNA-155 is a biomarker of T-cell activation and immune dysfunction in HIV-1-infected patients
    Jin, C.
    Cheng, L.
    Hoextermann, S.
    Xie, T.
    Lu, X.
    Wu, H.
    Skaletz-Rorowski, A.
    Brockmeyer, N. H.
    Wu, N.
    [J]. HIV MEDICINE, 2017, 18 (05) : 354 - 362
  • [46] Persistent Microbial Translocation and Immune Activation in HIV-1-Infected South Africans Receiving Combination Antiretroviral Therapy
    Cassol, Edana
    Malfeld, Susan
    Mahasha, Phetole
    van der Merwe, Schalk
    Cassol, Sharon
    Seebregts, Chris
    Alfano, Massimo
    Poli, Guido
    Rossouw, Theresa
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (05): : 723 - 733
  • [47] THE GROWTH OF HUMAN HIV-1-INFECTED U937 CELLS IN IMMUNE-DEPRIVED MICE
    CHERNUKHIN, IV
    CHEPURNOV, AA
    GAIDUL, KV
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 1995, 49 (7-8) : 358 - 363
  • [48] delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men
    Ellsworth, G. B.
    Lensing, S. Y.
    Ogilvie, C. B.
    Lee, J. Y.
    Goldstone, S. E.
    Berry-Lawhorn, J. M.
    Jay, N.
    Stier, E. A.
    Logan, J. S.
    Einstein, M. H.
    Saah, A.
    Mitsuyasu, R. T.
    Aboulafia, D.
    Palefsky, J. M.
    Wilkin, T. J.
    [J]. PAPILLOMAVIRUS RESEARCH, 2018, 6 : 11 - 14
  • [49] The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy
    Dyrhol-Riise, AM
    Stent, G
    Rosok, BI
    Voltersvik, P
    Olofsson, J
    Åsjö, B
    [J]. CLINICAL IMMUNOLOGY, 2001, 101 (02) : 169 - 179
  • [50] Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals
    Zangerle, R
    Steinhuber, S
    Sarcletti, M
    Dierich, MP
    Wachter, H
    Fuchs, D
    Möst, J
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1998, 116 (03) : 228 - 239
12345